Ca2+/calmodulin-dependent protein kinase II inhibitors potentiate superoxide production in polymorphonuclear leukocytes

J Pharm Pharmacol. 1999 Mar;51(3):295-300. doi: 10.1211/0022357991772475.

Abstract

The possible role of Ca2+/calmodulin-dependent protein kinase II (CaMK II) in superoxide anion (O2-) production induced by formyl-methionyl-leucyl-phenylalanine (FMLP) was investigated in mouse polymorphonuclear leukocytes (PMNs). KN-93 and KN-62, specific CaMK II inhibitors, augmented FMLP-induced O2- production. KN-92, an analogue which did not inhibit CaMK II, did not affect O2- production. W-7, a calmodulin inhibitor, augmented O2- production when administered at 30 mM for 5 min. KN-93 and recombinant mouse tumour necrosis factor-alpha (rmTNF-alpha) each augmented the maximal production of O2- induced by FMLP, and an additive effect of a combination of KN-93 and rmTNF-alpha was observed. CaMK II activity in the PMNs was increased by FMLP, and the increase was inhibited by KN-93 but not by rmTNF-alpha. These results suggest that the inhibition of CaMK II resulted in the augmentation of FMLP-induced O2- production in PMNs by a mechanism different from that of the augmentation shown by TNF-alpha.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives*
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • Animals
  • Benzylamines / pharmacology*
  • Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors*
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism
  • Drug Interactions
  • Enzyme Inhibitors / pharmacology
  • In Vitro Techniques
  • Male
  • Mice
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • Neutrophils / drug effects*
  • Neutrophils / metabolism
  • Sulfonamides / pharmacology*
  • Superoxides / metabolism*
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Benzylamines
  • Enzyme Inhibitors
  • Sulfonamides
  • Tumor Necrosis Factor-alpha
  • Superoxides
  • KN 93
  • N-Formylmethionine Leucyl-Phenylalanine
  • KN 62
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Calcium-Calmodulin-Dependent Protein Kinases